Work

The Role of Ribonucleotide Reductase in Inherited Purine Disorders

Year: 2022
Type: dissertation
Abstract: Adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) are consecutive enzymes in the purine degradation and salvage pathways. Inherited defects that abrogate ADA and PNP function result in the accumulation of dATP and dGTP respectively, which are toxic as they allosterically inhibit ribonucleotide reductase (RNR). RNR is responsible for the production of deoxyribonucleotides (dNTP) used for DNA synthesis. RNR inhibition contributes to the profound lymphopenia in ADA and PNP deficiency due to insufficient dNTPs required for DNA replication and cell proliferation. Additional tissues, however, may also suffer from the same pathology as lymphocytes. Neutropenia has been reported among both ADA-deficient patients and patients treated with the RNR inhibitor hydroxyurea (HU). Additionally, HU administration caused significant neurological abnormalities in mice and rats, similar to those observed in PNP-deficient mice. I therefore hypothesized that the neutropenia in ADA deficiency and neurological abnormalities in PNP deficiency are consequential to the purine metabolic disorders, with the inhibition of RNR being central to their pathogenesis. To address this, I utilized induced pluripotent stem cells (iPSC) derived from ADA- and PNP-deficient patients, as well as healthy control individuals. Differentiating the ADA-deficient iPSCs into neutrophils revealed a significant reduction in the number of hematopoietic progenitors and mature neutrophils. Hematopoietic colony formation revealed only granulocytes to be reduced by ADA deficiency, suggesting impaired neutrophil differentiation. Supplementing cultures with exogenous ADA enzyme successfully reversed the abnormalities, validating the role of ADA in neutrophil development. Differentiating PNP-deficient iPSCs into neurons revealed the induction of intrinsic mitochondrial-mediated apoptosis. Tumor protein p53 expression was also increased, and inhibition of p53 prevented the onset of apoptosis. Supplementing exogenous PNP enzyme successfully prevented the p53-mediated intrinsic apoptosis, validating the role of PNP in neuronal viability. To determine whether the RNR inhibition was responsible for the aforementioned phenotypes, control iPSCs were treated with the RNR inhibitors HU or with the combination of nicotinamide and trichostatin A. The inhibition of RNR recapitulated the ADA- and PNP-deficient phenotypes, demonstrating impaired neutrophil differentiation and increased neuronal apoptosis, highlighting the importance of RNR and the convergent mechanism responsible for the varied systemic abnormalities observed in these purine diseases.
Language: English
Open Access status: green
OpenAlex ID: W7133094811
Cites: 355
Cited by:
Related to: 10